Erythrodermic Psoriasis: Understanding the Risk of Severe Complications

February 5, 2024

Featured image for “Erythrodermic Psoriasis: Understanding the Risk of Severe Complications”

Erythrodermic psoriasis, also known as exfoliative psoriatic dermatitis, represents an uncommon but dangerous flare subtype affecting around 1-2% of psoriasis patients. This condition manifests as widespread fiery redness and shedding (exfoliation) of the skin, covering over 90% of the body surface area.

While most cases of psoriasis cause only mild to moderate skin symptoms, erythrodermic psoriasis can lead to severe illness with systemic complications. Fluid losses, metabolic disturbances, and infections may result. Mortality rates are substantially higher compared to limited plaque psoriasis.

This article provides an in-depth guide to erythrodermic psoriasis. We explore the symptoms, triggers, pathophysiology, diagnosis, treatments, and prognosis – including factors that influence mortality risk. Learning to recognize and manage this critical form of psoriasis is imperative.

Recognizing the Signs of Erythrodermic Psoriasis

During a flare, people with erythrodermic psoriasis develop thin, red, peeling skin affecting over 90 percent of their total body surface area. The clinical features include:

Skin Changes

  • Widespread bright red discoloration
  • Sheets of peeling, flaking skin
  • Generalized psoriatic plaques with fine scales
  • Loss of normal skin markings due to severe scaling

Systemic Symptoms

  • Chills, fever, tachycardia from inflammation
  • Dehydration and fluid/electrolyte imbalance
  • High cardiac output attempting to thermoregulate
  • Metabolic changes like protein loss and FATAL anemia

If untreated, these disturbances can progress to shock and multiorgan failure.

Therefore, recognizing an erythrodermic psoriasis flare early and seeking urgent care is vital before systemic instability sets in.

What Triggers This Severe Form of Psoriasis?

Erythrodermic psoriasis can arise either as:

  • An exacerbation of previously diagnosed plaque psoriasis
  • The initial presentation of psoriatic disease without prior skin lesions

Identified triggers leading to erythrodermic flares include:

  • Abrupt withdrawal of oral psoriasis medications
  • Infection – especially HIV/AIDS
  • Medications like lithium, antimalarials, beta blockers
  • Trauma, sunburn, severe stress
  • Rarely sponComorbid – no trigger found

Understanding these provoking factors allows patients on systemic psoriasis drugs to monitor for early signs of erythroderma if stopping treatment. Getting ahead of flares early is key.

Why Does Erythrodermic Psoriasis Occur?

The precise pathophysiology behind erythrodermic psoriasis is still under investigation. Likely contributors include:

  • Further dysregulation of already overactive psoriatic immune pathways
  • Activated Th17 T-cells secreting TNF-alpha, IL-17, IL-22
  • Disinhibition of interleukin-36 cytokines
  • Skin barrier disruption allowing systemic inflammation

This runaway immune response spreads psoriatic plaque formation across the entire integument. Skin barrier breakdown then allows systemic absorption of inflammatory mediators and fluid losses.

Diagnosing Erythrodermic Psoriasis

Given the nonspecific initial red rash, erythrodermic psoriasis may be mistaken for other causes of exfoliative dermatitis like:

  • Severe eczema
  • Pityriasis rubra pilaris
  • Drug-induced skin reactions
  • Cutaneous T-cell lymphoma

A skin biopsy helps confirm the diagnosis by demonstrating classic psoriatic microscopic findings – like Munro microabscesses and confluent parakeratosis.

Testing for provoking conditions like HIV or antinuclear antibodies should be performed. Cultures may identify precipitating infections.

Overall though, the clinical features combined with a prior history of psoriasis usually suffices for recognizing erythrodermic flares.

Treatment Options for Erythrodermic Psoriasis

All patients with erythrodermic psoriasis require hospitalization – often in a burn unit or intensive care setting due to disease severity. Treatment focuses on four aspects:

  • Supportive therapy – IV fluids, electrolyte monitoring, thermoregulation measures, high-protein diet
  • Infection control – wound care, reverse isolation, antibiotics if indicated
  • Reducing inflammation – systemic immunosuppressants like oral steroids or biologics targeting TNF-alpha
  • Modulating skin growth – retinoids, vitamin D analogs

Phototherapy and topical agents play more limited roles until inflammation improves.

Following discharge, transitioning to an oral systemic or biologic medication regimen maintains remission in erythrodermic psoriasis. This helps prevent recurrences of severe flares.

What Is the Prognosis for Erythrodermic Psoriasis Patients?

The published mortality rate for erythrodermic psoriasis varies widely – ranging from 10 to 65 percent across studies. The most frequent causes of erythrodermic psoriasis death include:

  • Sepsis
  • Pneumonia
  • Congestive heart failure exacerbated by high cardiac output demands
  • Arrhythmias, myocardial infarction – either sponComorbid or due to demand ischemia

Older individuals and those with underlying health conditions are most prone to adverse outcomes. Even with treatment, erythrodermic psoriasis carries substantially higher mortality than milder forms.

With comprehensive inpatient management and careful post-discharge planning, many patients do recover fully. But the acute instability and increased infection risk make erythrodermic flares dangerous.

Maintaining disease control on systemic medications helps reduce recurrence risk once erythroderma resolves. Mild topical therapy can then often prevent future crises.

Frequently Asked Questions About Erythrodermic Psoriasis

Does erythrodermic psoriasis go away?

Yes, with appropriate treatment, the acute inflammatory flare causing widespread redness and skin peeling can resolve after hospitalization. However, the underlying psoriasis remains.

Ongoing oral or biologic medications are usually required to prevent erythrodermic recurrences. Topical steroids and vitamin D analogs may supplement maintenance treatment in some milder cases.

What should I do if I think I’m developing erythroderma?

Seek urgent medical attention as soon as possible. Call your dermatologist’s emergency number or go to the nearest ER. The high mortality rate makes rapidly controlling erythrodermic flares imperative.

Correct diagnosis and intensive inpatient care gives the best outcomes. Waiting leads to increased fluid shifts, metabolic disturbances and higher infection risks.

Can erythrodermic psoriasis recur after resolving?

Yes, unfortunately even with treatment, some erythrodermic psoriasis patients experience repeat flares intermittently. Triggers like medication changes, illness or trauma precipitate recurrence risk.

Using oral systemic or biologic drugs continuously reduces but doesn’t eliminate chances of repeat crises.Patients who have had erythroderma need vigilant long-term monitoring and management.

Are there alternative treatments for erythrodermic psoriasis?

Emerging research shows JAK inhibitors like tofacitinib may successfully treat erythrodermic flares. These novel oral medications block upstream inflammatory cytokines driving psoriatic immunopathology.

For patients not responding adequately to TNF inhibitors, talking to your dermatologist about clinical trials with JAK inhibitors could be worthwhile to help manage recurrent erythrodermic psoriasis.

What should I know about living with erythrodermic psoriasis?

Coping with the severe, widespread skin inflammation can be challenging physically and emotionally. Connecting with others through support groups helps many patients.

Avoiding trigger exposures, adhering to treatments, and promptly reporting concerning symptoms to your providers gives the best outcomes long-term. Working closely with your dermatologist prevents crises.

Key Takeaways on Erythrodermic Psoriasis

  • Erythrodermic psoriasis causes severe, widespread skin redness and shedding unlike limited plaque lesions
  • Hospitalization for supportive care, infection prevention, and inflammation reduction is required
  • Reported mortality rates vary from 10-65% – much greater than mild psoriasis
  • Prompt treatment helps resolution of the acute erythrodermic flare
  • Preventing recurrences involves long-term systemic or biologic medications
  • Excellent skin care and monitoring allows patients to manage this severe psoriasis form

In summary, erythrodermic psoriasis represents an uncommon but dangerous disease. Seeking emergency dermatology care at the earliest signs of an impending flare, then closely following providers’ advice for maintenance therapy thereafter, offers the best odds of staying stable long-term.

5/5 - (1 vote)

Related articles


Cold Plasma System

The world's first handheld cold plasma device

Learn More

Made in USA